Prospeo
Hero Section BackgroundHero Section Background
Compass Therapeutics

Compass Therapeutics Email Formats

Biotechnology ResearchFlag of USBoston, Massachusetts, United States21-50 Employees

Compass Therapeutics Email Formats

Compass Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@compasstherapeutics.com), used 64.3% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@compasstherapeutics.com
64.3%
{first initial}.{last name}
j.doe@compasstherapeutics.com
35.7%

Key Contacts at Compass Therapeutics

Flag of US

Li Chen

Director Cmc And Msat

Flag of US

Alberto Visintin

Sr. Director - Head Of Immunology And Preclinical Research

Flag of US

Mara Shainheit

Director - Translational Science

Flag of US

Thomas Schuetz

Co-Founder, Ceo, Vice Chairman Of The Board

Flag of US

Neal Schilling

Director - Manufacturing

Flag of US

Natalie Warholic

Director, Clinical Operations

Flag of US

Diana Albu

Associate Director

Company overview

Headquarters80 Guest Street, Suite 601, Boston, MA 02135, US
Phone number+16175008099
Website
NAICS541714
SIC873
Keywords
Oncology, Biologics, Immuno-Oncology, Drug Discovery And Development
Founded2014
Employees21-50
Socials

About Compass Therapeutics

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. To learn more, visit www.compasstherapeutics.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Manager
Vice President

Employees by Department

Compass Therapeutics has 14 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Compass Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2020-08-011$60,500,000
2022-12-0214$80,000,000
2025-09-1214$120,000,000

Funding Insights

$260,500,000

Total funding amount

$120,000,000

Most recent funding amount

3

Number of funding rounds

Compass Therapeutics Tech Stack

Discover the technologies and tools that power Compass Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Draftpress HFCM

Draftpress HFCM

WordPress plugins

Twitter Emoji

Font scripts

Google Hosted Libraries

Google Hosted Libraries

CDN

jQuery

jQuery

JavaScript libraries

Google Tag Manager

Google Tag Manager

Tag managers

Nginx

Nginx

Reverse proxies

PHP

PHP

Programming languages

FancyBox

FancyBox

JavaScript libraries

Font Awesome

Font Awesome

Font scripts

WordPress

WordPress

Blogs

Google Analytics

Google Analytics

Analytics

DocuSign

DocuSign

Miscellaneous

Frequently asked questions

Compass Therapeutics is located in Boston, Massachusetts, US.
You can reach Compass Therapeutics at +16175008099.
Compass Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.
Compass Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Compass Therapeutics has raised a total of $260,500,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles